SK Bioscience

SK Bioscience is a global leader in vaccine and biopharmaceutical development and production, dedicated to advancing human health. Operating within the Chemicals, Petrochemicals, Glass & Gases, and Manufacturing sectors, the company drives innovation through specialized research and development. Their mission focuses on creating novel solutions for disease prevention and treatment, establishing them as a significant force in global health. SK Bioscience actively participates in domestic and international markets, fostering collaborations and technology transfers to expand the availability of critical medical products.

The company maintains a substantial operational scale, employing between 1,000 and 5,000 professionals. This workforce supports their robust capacity in the biopharmaceutical sector, enabling comprehensive contract development and manufacturing organization (CDMO) and contract manufacturing organization (CMO) services. These services assist partners in bringing vital medical advancements to market. Their revenue stands at $253.2M, reflecting their significant market presence and financial stability. To learn more about the individuals driving these advancements, consider exploring: Meet SK Bioscience's team.

SK Bioscience's strategic focus on innovation and collaboration addresses unmet medical needs globally. Through rigorous scientific inquiry and advanced manufacturing, they contribute substantially to the biopharmaceutical ecosystem. Their product offerings include essential vaccines and biopharmaceutical agents, all engineered to enhance human well-being and public health. SK Bioscience's commitment to excellence and forward-thinking strategies solidify its position as a trusted partner in the global pursuit of a healthier future.